Hedge Funds Show Interest in Abbott Laboratories in Recent Filings
Recent 13F filings for the reporting period ending March 31, 2025, reveal that 16 hedge funds have included Abbott Laboratories (Symbol: ABT) in their portfolios. This concentration prompts a closer examination of fund manager behaviors.
It’s essential to acknowledge that 13F filings only disclose funds’ long positions with the SEC, while short positions remain hidden. For instance, a hedge fund may hold a long position while simultaneously shorting the stock, creating a potentially misleading impression of bullishness from the 13F data.
Despite this limitation, analyzing groups of 13F filings provides valuable insights, especially when making comparisons across reporting periods. Below, we review the changes in ABT positions among the latest filers:
| Fund | New Position? | Change In Share Count | Change In Market Value ($ in 1000’s) |
|---|---|---|---|
| Rench Wealth Management Inc. | Existing | –170 | +$1,317 |
| Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. | Existing | –16 | +$322 |
| Federation des caisses Desjardins du Quebec | Existing | –28,294 | +$742 |
| S&T Bank PA | Existing | –691 | +$103 |
| First Financial Bankshares Inc | Existing | +1,305 | +$2,311 |
| Dark Forest Capital Management LP | NEW | +2,389 | +$317 |
| EP Wealth Advisors LLC | Existing | +7,713 | +$2,106 |
| First Manhattan CO. LLC. | Existing | –1,516 | +$882 |
| GW Henssler & Associates Ltd. | Existing | +980 | +$183 |
| Capital Investment Counsel LLC | Existing | –1,237 | –$55 |
| Cigna Investments Inc. New | Existing | –236 | +$313 |
| 1248 Management LLC | Existing | –2,732 | –$190 |
| Focus Partners Advisor Solutions LLC | Existing | –1,206 | +$239 |
| PDT Partners LLC | Existing | +7 | +$298 |
| Ashton Thomas Securities LLC | Existing | +201 | +$93 |
| Rakuten Investment Management Inc. | NEW | +158,531 | +$20,739 |
| Aggregate Change: | +135,028 | +$29,720 | |
Among the reporting funds, five increased their ABT positions from December 31, 2024, to March 31, 2025. Meanwhile, nine funds reduced their holdings, and two established new positions.
Looking at all funds holding ABT within the total 6,128 we examined, we compared the aggregate share count at both March 31, 2025, and December 31, 2024. Funds increased their collective holdings by 11,387,970 shares, rising from 1,076,038,651 to 1,087,426,621—an approximate increase of 1.06%. The top three funds holding ABT as of March 31, 2025, are noteworthy.
As we continue to monitor the latest 13F filings, patterns among hedge fund managers will be explored. Examining aggregate data from different reporting periods can yield findings of significance, offering stock research opportunities like those presented by Abbott Laboratories (Symbol: ABT).
10 S&P 500 Components Hedge Funds Are Buying »
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
